0001209191-19-048980.txt : 20190909
0001209191-19-048980.hdr.sgml : 20190909
20190909195023
ACCESSION NUMBER: 0001209191-19-048980
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190905
FILED AS OF DATE: 20190909
DATE AS OF CHANGE: 20190909
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaufmann Gunnar F.
CENTRAL INDEX KEY: 0001786754
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50549
FILM NUMBER: 191084087
MAIL ADDRESS:
STREET 1: C/O ONCTERNAL THERAPEUTICS, INC.
STREET 2: 12230 EL CAMINO REAL, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc.
CENTRAL INDEX KEY: 0001260990
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 621715807
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 434-1113
MAIL ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: GTX INC /DE/
DATE OF NAME CHANGE: 20030822
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-09-05
0
0001260990
Oncternal Therapeutics, Inc.
ONCT
0001786754
Kaufmann Gunnar F.
12230 EL CAMINO REAL, SUITE 300
SAN DIEGO
CA
92130
0
1
0
0
Chief Scientific Officer
Stock Option
5.19
2019-09-05
4
A
0
150000
0.00
D
2029-09-05
Common Stock
150000
150000
D
One-fourth (1/4th) of the shares subject to the stock options shall vest on first anniversary of the date of grant, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments over the three-year period thereafter, subject to the Reporting Person's continued employment or service with the Issuer on each such date.
/s/ Hazel M. Aker, Attorney-in-fact
2019-09-09